Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
196 | 3 | LUNG CANCER//NON SMALL CELL LUNG CANCER//THORAC SURG | 53631 |
440 | 2 | GEFITINIB//EGFR//EPIDERMAL GROWTH FACTOR RECEPTOR | 16519 |
6250 | 1 | NIMOTUZUMAB//CETUXIMAB//EGFR | 1535 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | NIMOTUZUMAB | authKW | 670477 | 4% | 56% | 58 |
2 | CETUXIMAB | authKW | 332096 | 11% | 10% | 166 |
3 | EGFR | authKW | 281691 | 18% | 5% | 281 |
4 | EPIDERMAL GROWTH FACTOR RECEPTOR | authKW | 236828 | 14% | 5% | 211 |
5 | NUCLEAR EGFR | authKW | 231306 | 1% | 87% | 13 |
6 | RADIOBIOL MOL ENVIRONM | address | 229107 | 2% | 45% | 25 |
7 | H R3 | authKW | 97813 | 1% | 53% | 9 |
8 | HEAD AND NECK SQUAMOUS CELL CARCINOMA | authKW | 97150 | 5% | 6% | 75 |
9 | C225 | authKW | 95352 | 1% | 39% | 12 |
10 | EGFR INHIBITION | authKW | 82593 | 1% | 31% | 13 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 29179 | 70% | 0% | 1082 |
2 | Radiology, Nuclear Medicine & Medical Imaging | 1110 | 11% | 0% | 176 |
3 | Otorhinolaryngology | 853 | 5% | 0% | 82 |
4 | Dentistry, Oral Surgery & Medicine | 361 | 4% | 0% | 67 |
5 | Cell Biology | 272 | 9% | 0% | 135 |
6 | Medicine, Research & Experimental | 112 | 4% | 0% | 68 |
7 | Pharmacology & Pharmacy | 98 | 7% | 0% | 113 |
8 | Pathology | 88 | 3% | 0% | 43 |
9 | Biochemistry & Molecular Biology | 9 | 7% | 0% | 111 |
10 | Biotechnology & Applied Microbiology | 8 | 3% | 0% | 40 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | RADIOBIOL MOL ENVIRONM | 229107 | 2% | 45% | 25 |
2 | ONCOPHARMACOL UNIT | 77172 | 1% | 20% | 19 |
3 | HUMAN ONCOL | 60921 | 4% | 5% | 56 |
4 | CONSORTIUM PHASE 2 | 41061 | 0% | 100% | 2 |
5 | EXPT HEAD NECK ONCOL | 41061 | 0% | 100% | 2 |
6 | TUMOR N LES | 41061 | 0% | 100% | 2 |
7 | RADIOBIOL EXPT RADIOONCOL | 39413 | 1% | 17% | 11 |
8 | ONCORAY ZENTRUM STRAHLENFOR ONKOL | 36952 | 0% | 60% | 3 |
9 | TUMOUR BIOL METASTASIS TEAM | 36494 | 0% | 44% | 4 |
10 | MCELWAIN S | 34565 | 1% | 21% | 8 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ORAL ONCOLOGY | 13143 | 3% | 1% | 45 |
2 | CLINICAL CANCER RESEARCH | 12546 | 6% | 1% | 97 |
3 | RADIOTHERAPY AND ONCOLOGY | 11222 | 4% | 1% | 58 |
4 | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 6487 | 3% | 1% | 40 |
5 | SEMINARS IN RADIATION ONCOLOGY | 4226 | 1% | 2% | 13 |
6 | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2864 | 3% | 0% | 50 |
7 | CANCER BIOLOGY & THERAPY | 2837 | 1% | 1% | 20 |
8 | INTERFERON Y BIOTECNOLOGIA | 2828 | 0% | 7% | 2 |
9 | CURRENT OPINION IN ONCOLOGY | 2776 | 1% | 1% | 14 |
10 | BULLETIN DU CANCER | 2504 | 1% | 1% | 23 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NIMOTUZUMAB | 670477 | 4% | 56% | 58 | Search NIMOTUZUMAB | Search NIMOTUZUMAB |
2 | CETUXIMAB | 332096 | 11% | 10% | 166 | Search CETUXIMAB | Search CETUXIMAB |
3 | EGFR | 281691 | 18% | 5% | 281 | Search EGFR | Search EGFR |
4 | EPIDERMAL GROWTH FACTOR RECEPTOR | 236828 | 14% | 5% | 211 | Search EPIDERMAL+GROWTH+FACTOR+RECEPTOR | Search EPIDERMAL+GROWTH+FACTOR+RECEPTOR |
5 | NUCLEAR EGFR | 231306 | 1% | 87% | 13 | Search NUCLEAR+EGFR | Search NUCLEAR+EGFR |
6 | H R3 | 97813 | 1% | 53% | 9 | Search H+R3 | Search H+R3 |
7 | HEAD AND NECK SQUAMOUS CELL CARCINOMA | 97150 | 5% | 6% | 75 | Search HEAD+AND+NECK+SQUAMOUS+CELL+CARCINOMA | Search HEAD+AND+NECK+SQUAMOUS+CELL+CARCINOMA |
8 | C225 | 95352 | 1% | 39% | 12 | Search C225 | Search C225 |
9 | EGFR INHIBITION | 82593 | 1% | 31% | 13 | Search EGFR+INHIBITION | Search EGFR+INHIBITION |
10 | HNSCC | 79731 | 3% | 8% | 50 | Search HNSCC | Search HNSCC |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |